A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 2, 1999, Pages 293-298

  Hudes, Richard S ^a   Corn, Benjamin W ^a   Werner Wasik, Maria ^a   Andrews, David ^a   Rosenstock, Jeffrey ^b   Thoron, Louisa ^a   Downes, Beverly ^a   Curran Jr , Walter J ^a,c  

^a WILLS EYE HOSPITAL   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Glioma; Stereotactic radiotherapy; Toxicity

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GLIOMA; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TUMOR RECURRENCE; TUMOR VOLUME;

BRAIN NEOPLASMS; DOSE FRACTIONATION; GLIOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033556615     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00416-7     Document Type: Article

References (29)

1. Curran W.J. Jr, Scott C.B., Horton J., Nelson J.S., Weinstein A.S., Fischbach J., Chang C.H., Rotman M., Asbell S.O., Krisch R.E., Nelson D.F. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Canc Inst. 85:1993;704-710.
2. Wallner K.E., Galicich J.H., Krol G., Arbit E., Malkin M.G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 16:1989;1405-1409.
3. Bernstein M., Laperriere N., Glen J., Leung P., Thomason C., Landon A. Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys. 30:1994;1213-1217.
4. Chamberlain M.C., Barba D., Kormanik P., Shea W.M.C. Stereotactic radiosurgery for recurrent gliomas. Cancer. 74:1994;1342-1346.
5. Gutin P.H., Prados M.D., Phillips T.L., Wara W.M., Larson D.A., Leibel S.A., Sneed P.K., Levin V.A., Weaver K.A., Silver P., Lamborn K., Lamb S., Ham B. External irradiation followed by an interstitital high activity iodine-125 "boost" in the initial treatment of malignant gliomas NCOG Study 6G-82-2 . Int J Radiat Oncol Biol Phys. 21:1991;601-606.
6. Hall W.A., Djalilian H.R., Sperduto P.W., Cho K.H., Gerbi B.J., Gibbons J.P., Rohr M., Clark H.B. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol. 13:1995;1642-1648.
7. Leibel S.A., Gutin P.H., Wara W.M., Silver P.S., Larson D.A., Edwards M.B., Lamb S.A., Ham B., Weaver K.A., Barnett C., Phillips T.L. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 17:1989;1129-1139.
8. Mehta M.P., Masciopinto J., Rozental J., Levin A., Chappell R., Bastin K., Miles J., Turski P., Kubsad S., Mackie T., Kinsella T. Stereotactic radiosurgery for glioblastoma multiforme Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage . Int J Radiat Oncol Biol Phys. 30:1994;541-549.
9. Scharfen C.O., Sneed P.K., Wara M.W., Larson D.A., Phillips T.L., Prados M.D., Weaver K.A., Malec M., Acord P., Lamborn K.R., Lamb S.A., Ham B., Gutin P.H. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys. 24:1992;583-591.
10. Shrieve D.C., Alexander E., Wen P.Y., Fine H.A., Kooy H.M., Black P.M., Loeffler J.S. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 36:1995;275-284.
11. Corn B.W., Curran W.J., Shrieve D.C., Loeffler J.S. Stereotactic radiosurgery and radiotherapy New developments and new directions . Sem Clin Oncol. 24:1997;707-714.
12. Macdonald D.R., Cascino T.L., Schold S.C., Caincross J.G. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 8:1990;1277-1280.
13. Gill S.S., Thomas D.G. Relocatable frame for stereotactic external beam radiotherapy. Int J Radiat Oncol Biol Phys. 29:1991;599-603.
14. Chamberlain M.C., Kormanik P. Salvage chemotherapy with paclitaxel for recurrent primary brain tumors. J Clin Oncol. 13:1995;2066-2071.
15. Lesser G.J., Grossman S. The chemotherapy of high-grade astrocytomas. Semin Oncol. 21:1994;220-235.
16. Newton H.B., Junck L., Bromberg J., Page M.A., Greenberg H.S. Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosurea failure. Neurology. 40:1990;1743-1746.
17. Ammirati A., Galicich J.H., Arbit E., Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 21:1987;607-614.
18. Salcman M., Kaplan R.S., Ducker T.B., Abdo H., Montgomery E. Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery. 10:1982;454-463.
19. Stromblad L.G., Anderson H., Salford M., Salford L.G. Reoperation for malignant astrocytomas Personal experience and a review of the literature . Br J Neurosurg. 7:1993;623-633.
20. Brem H., Piantadosi S., Burger P.C., Walker M., Selker R., Vick N.A., Black K., Sisti M., Brem S., Mohr G., Muller P., Morawetz R., Schold S.C. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet. 345:1995;1008-1012.
21. Alexander E., Loeffler J.S. Radiosurgery using a modified linear accelerator. Neurosurg Clin North Am. 3:1992;167-190.
22. Florell R.C., MacDonald D.R., Irish W.D., Bernstein M., Leibel S.A., Gutin P.H., Caincross J.G. Selection bias, survival, and brachytherapy for glioma. J Neurosurgery. 76:1992;179-183.
23. Kim H.K., Thornton A.F., Greenberg H.S., Page M.A., Junck L., Sandler H.M. Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol. 20:1997;358-363.
24. Laing R.W., Warrington A.P., Graham J., Britton J., Hines F., Brada M. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiother Oncol. 27:1993;22-29.
25. Shepherd S.F., Laing R.W., Cosgrove V.P., Warrington A.P., Hines F., Ashley S., Brada M. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys. 37:1997;393-398.
26. Glass J., Silverman C.L., Axelrod R., Corn B.W., Andrews D.W. Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol. 20:1997;226-229.
27. Lederman G., Arbit E., Odaimi M., Lombardi E., Wrzolek M., Wronski M. Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme A preliminary report . Int J Radiat Oncol Biol Phys. 40:1998;661-666.
28. 125I brachytherapy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys. 35:1996;541-547.
29. Sneed P.K. Brachytherapy and hyperthermia for malignant astrocytomas. Semin Oncol. 21:1994;186-197.